Al-Maidan Clinic for Oral Health Services Company K.S.C.P. (KWSE:MIDAN)
Kuwait
· Delayed Price · Currency is KWD · Price in KWF 0.819
0.00 (0.00%)
At close: Mar 9, 2026
KWSE:MIDAN Income Statement
Financials in millions KWD. Fiscal year is April - March.
Millions KWD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 63.44 | 72 | 75.75 | 72.6 | 70.82 | 60.94 | Upgrade
|
| Revenue Growth (YoY) | -16.40% | -4.96% | 4.35% | 2.52% | 16.21% | 10.27% | Upgrade
|
| Cost of Revenue | 51.65 | 53.16 | 53.64 | 47.69 | 47.01 | 40.17 | Upgrade
|
| Gross Profit | 11.79 | 18.84 | 22.12 | 24.91 | 23.81 | 20.77 | Upgrade
|
| Selling, General & Admin | 4.95 | 8.83 | 9.09 | 8.47 | 8.88 | 9.96 | Upgrade
|
| Other Operating Expenses | 0.31 | 0.36 | 0.39 | 0.44 | 0.38 | 0.33 | Upgrade
|
| Operating Expenses | 8.23 | 12.72 | 12.32 | 12.02 | 10.61 | 13.92 | Upgrade
|
| Operating Income | 3.55 | 6.12 | 9.8 | 12.89 | 13.2 | 6.86 | Upgrade
|
| Interest Expense | -0.12 | -0.11 | -0.17 | -0.1 | -0.1 | -0.12 | Upgrade
|
| Interest & Investment Income | 2.03 | 2.03 | 2.16 | 0.18 | 0.09 | 0.04 | Upgrade
|
| Earnings From Equity Investments | 0.18 | -0.28 | -0.36 | -1.07 | -0.05 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 1.07 | 1.89 | 0.72 | 1.39 | 0.93 | 0.67 | Upgrade
|
| EBT Excluding Unusual Items | 6.72 | 9.65 | 12.15 | 13.29 | 14.07 | 7.44 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.63 | 1.27 | 0.15 | -0.67 | -1.37 | 0.44 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | - | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | 0.02 | -2.16 | - | Upgrade
|
| Other Unusual Items | -0.57 | -1.49 | -0.34 | -0.31 | -0.13 | 0.05 | Upgrade
|
| Pretax Income | 6.76 | 9.41 | 11.97 | 12.34 | 10.41 | 7.93 | Upgrade
|
| Income Tax Expense | 0.12 | 0.14 | 0.16 | 0.18 | 0.15 | 0.13 | Upgrade
|
| Earnings From Continuing Operations | 6.64 | 9.27 | 11.81 | 12.16 | 10.25 | 7.8 | Upgrade
|
| Minority Interest in Earnings | -0.01 | -0 | 0.01 | 0.02 | 0.03 | 0 | Upgrade
|
| Net Income | 6.63 | 9.27 | 11.82 | 12.18 | 10.28 | 7.81 | Upgrade
|
| Net Income to Common | 6.63 | 9.27 | 11.82 | 12.18 | 10.28 | 7.81 | Upgrade
|
| Net Income Growth | -41.87% | -21.57% | -3.00% | 18.49% | 31.70% | 21.60% | Upgrade
|
| Shares Outstanding (Basic) | 203 | 203 | 206 | 224 | 225 | 225 | Upgrade
|
| Shares Outstanding (Diluted) | 203 | 203 | 206 | 224 | 225 | 225 | Upgrade
|
| Shares Change (YoY) | 1.91% | -1.88% | -7.81% | -0.50% | - | - | Upgrade
|
| EPS (Basic) | 0.03 | 0.05 | 0.06 | 0.05 | 0.05 | 0.03 | Upgrade
|
| EPS (Diluted) | 0.03 | 0.05 | 0.06 | 0.05 | 0.05 | 0.03 | Upgrade
|
| EPS Growth | -42.96% | -20.07% | 5.22% | 19.09% | 31.70% | 21.60% | Upgrade
|
| Free Cash Flow | 7.23 | 8.98 | 12.57 | 13.62 | 19.94 | 6.9 | Upgrade
|
| Free Cash Flow Per Share | 0.04 | 0.04 | 0.06 | 0.06 | 0.09 | 0.03 | Upgrade
|
| Dividend Per Share | 0.015 | 0.015 | 0.010 | 0.006 | - | 0.011 | Upgrade
|
| Dividend Growth | 50.00% | 50.00% | 78.57% | - | - | 42.31% | Upgrade
|
| Gross Margin | 18.58% | 26.17% | 29.20% | 34.32% | 33.62% | 34.09% | Upgrade
|
| Operating Margin | 5.60% | 8.50% | 12.94% | 17.76% | 18.64% | 11.25% | Upgrade
|
| Profit Margin | 10.45% | 12.87% | 15.60% | 16.78% | 14.52% | 12.81% | Upgrade
|
| Free Cash Flow Margin | 11.40% | 12.47% | 16.60% | 18.75% | 28.16% | 11.32% | Upgrade
|
| EBITDA | 5.9 | 8.39 | 11.82 | 14.63 | 14.84 | 10.11 | Upgrade
|
| EBITDA Margin | 9.30% | 11.65% | 15.61% | 20.16% | 20.96% | 16.59% | Upgrade
|
| D&A For EBITDA | 2.35 | 2.26 | 2.02 | 1.74 | 1.64 | 3.26 | Upgrade
|
| EBIT | 3.55 | 6.12 | 9.8 | 12.89 | 13.2 | 6.86 | Upgrade
|
| EBIT Margin | 5.60% | 8.50% | 12.94% | 17.76% | 18.64% | 11.25% | Upgrade
|
| Effective Tax Rate | 1.85% | 1.53% | 1.31% | 1.45% | 1.46% | 1.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.